Medi&Gene Inc.
58Patents
29Active
58Granted
44Portfolio score
Filing activity: Feb 26, 1998 → Sep 11, 2019 · 14 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7329731B2 | Soluble T cell receptor | Human Necessities | 75 | Expired |
| US6207453A | Recombinant AAV vector-based transduction system and use of same | Chemistry; Metallurgy | 73 | Expired |
| US7314912B1 | AAv scleroprotein, production and use thereof | Chemistry; Metallurgy | 71 | Expired |
| US7968340B2 | Structural protein of adeno-associated virus with modified antigenicity, its production and its use | Chemistry; Metallurgy | 56 | Active |
| US7252997B1 | Structural protein of adeno-associated virus with modified antigenicity, its production and its use | Chemistry; Metallurgy | 51 | Expired |
| US6846665B1 | Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament | Chemistry; Metallurgy | 48 | Expired |
| US9464119B2 | Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3 | Chemistry; Metallurgy | 33 | Active |
| US9624274B2 | Mutated structural protein of a parvovirus | Chemistry; Metallurgy | 32 | Active |
| US7285381B1 | Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same | Chemistry; Metallurgy | 30 | Expired |
| US7001765B2 | Adeno-associated virus vector for boosting immunogenicity of cells | Chemistry; Metallurgy | 29 | Expired |
| US7556965B2 | Structural protein of adeno-associated virus with modified antigenicity, its production and its use | Chemistry; Metallurgy | 27 | Active |
| US7749745B2 | Viral vectors and their use in therapeutic methods | Chemistry; Metallurgy | 25 | Expired |
| US6352696B1 | Papillomavirus truncated L1 protein and fusion protein constructs | Emerging Cross-Sectional Technologies | 23 | Expired |
| US9060998B2 | Use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin | Human Necessities | 20 | Active |
| US6649167B2 | Papillomavirus truncated L1 protein and fusion protein constructs | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6277621A | Artificial chromosome constructs containing foreign nucleic acid sequences | Chemistry; Metallurgy | 11 | Expired |
| US6479273B1 | Filtration method for separating viruses | Chemistry; Metallurgy | 9 | Expired |
| US7858662B2 | Medicament for the treatment of viral skin and tumour diseases | Human Necessities | 8 | Active |
| US7276505B2 | Immunomodulating heterocyclic compounds | Chemistry; Metallurgy | 5 | Expired |
| US8138313B2 | Treatment of tumors using specific anti-L1 antibody | Chemistry; Metallurgy | 4 | Active |
| US6562351B2 | Papilloma truncated L1 protein and fusion protein constructs | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7618452B2 | Artificially produced, three-dimensional muscle tissue | Chemistry; Metallurgy | 3 | Expired |
| US7182947B2 | Papillomavirus truncated L1 protein and fusion protein constructs | Chemistry; Metallurgy | 3 | Expired |
| US7078543B2 | Methods for producing oxirane carboxylic acids and derivatives thereof | Chemistry; Metallurgy | 3 | Expired |
| US6838084B1 | Cytotoxic T-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy | Chemistry; Metallurgy | 3 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.